Cost-effectiveness of automated external defibrillators in public places: Con

Current Opinion in Cardiology

Volumn 22, Issue 1, 2007, Pages 5-10

  Pell, Jill P ^a   Walker, Andrew ^a   Cobbe, Stuart M ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Automated external defibrillator; Cost effectiveness; Cost utility; Public access defibrillation; Resuscitation

Indexed keywords

AUTOMATED EXTERNAL DEFIBRILLATOR; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESUSCITATION; REVIEW; SURVIVAL RATE;

COST-BENEFIT ANALYSIS; DEFIBRILLATORS; EMERGENCY TREATMENT; HEART ARREST; HUMANS; PUBLIC FACILITIES; RESUSCITATION;

EID: 33845438451     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3280118fec     Document Type: Review

References (51)

1. Evans T. Cardiac arrests outside hospital. Br Med J 1998; 316:1031-1032.
2. Pell JP, Sirel JM, Marsden A, et al. Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. Br Med J 2001; 322:1385-1388.
3. ECC Committee, Subcommittee and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112 (Suppl IV):IV1-203. Comprehensive review of evidence and guidelines on all aspects of resuscitation.
4. Hazinski MF, Idris AH, Kerber RE, et al. Lay rescuer automated external defibrillator ('public access defibrillation') programs: lessons learned from an international multicenter trial: advisory statement from the American Heart Association Emergency Cardiovascular Committee; the Council on Cardiopulmonary, Perioperative, and Critical Care and the Council on Clinical Cardiology. Circulation 2005; 111:3336-3340. Discussion of implications of PAD trial results for public policy.
5. Nichol G, Hallstrom AP, Kerber R, et al. American Heart Association report on the Second Public access Defibrillation Conference, April 17-19, 1997. Circulation 1998; 97:1309-1314.
6. White RD, Bunch TJ, Hankins DG. Evolution of a community-wide early defibrillation programme experience over 13 years using police/fire personnel and paramedics as responders. Resuscitation 2005; 65:279-283. Police/fire first responders with AEDs achieved similar survival rates to paramedics.
7. Valenzuela TD, Roe DJ, Nicol G, et al. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 2000; 343:1206-1209.
8. Page RL, Joglar JA, Kowal RC, et al. Use of automated external defibrillators by a US airline. N Engl J Med 2000; 343:1210-1216.
9. O'Rourke MF, Donaldson E, Geddes JS. An airline cardiac arrest program. Circulation 1997; 96:2849-2853.
10. Caffrey SL, Willoughby PJ, Pepe PE, Becker LB. Public use of automated external defibrillators. N Engl J Med 2002; 347:1242-1247.
11. Whitfield R, Colquhoun M, Chamberlain D, et al. The Department of Health National Defibrillator Programme: analysis of downloads from 250 deployments of public access defibrillators. Resuscitation 2005; 64:269-277. Initial results from pilot of a national PAD scheme.
12. Hallstrom AP, Ornato JP, Weisfeldt M, et al., Public Access Defibrillation Trial Investigators. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004; 351:637-646.
13. Peberdy MA, Ottingham LV, Groh WJ, et al., PAD Investigators. Adverse events associated with lay emergency response programs: the public access defibrillation trial experience. Resuscitation 2006; 70:59-65. Very low incidence of patient, volunteer or device-related adverse events in the PAD trial.
14. Pell JP, Sirel JM, Marsden AK, et al. Potential impact of public access defibrillators on overall survival following out of hospital cardiopulmonary arrest. Br Med J 2002; 325:515-517.
15. Becker LB, Eisenberg M, Fahrenbruch C, Cobb L. Public locations of cardiac arrest. Implications for public access defibrillation. Circulation 1998; 97:2106-2109.
16. Gratton M, Lindholm DJ, Campbell JP. Public access defibrillation: Where do we place the AEDs? Prehosp Emerg Care 1999; 3:303-305.
17. Engdahl J, Herlitz J. Localization of out-of-hospital cardiac arrest in Goteborg 1994-2002 and implications for public access defibrillation. Resuscitation 2005; 64:171-175. A high proportion of arrests occur in nonacute healthcare settings; 2.5% of arrests occurred in potential PAD sites.
18. Muraoka H, Ohishi Y, Hazui H, et al. Location of out-of-hospital cardiac arrests in Takatsuki City: where should automatic external defibrillator be placed? Circ J 2006; 70:827-831.
19. Fedoruk JC, Currie WL, Gobet M. Locations of cardiac arrest: affirmation for community Public Access Defibrillation (PAD) Program. Prehosp Disaster Med 2002; 17:202-205.
20. Malcom GE, Thompson TM, Coule PL. The location and incidence of out-of-hospital cardiac arrest in Georgia: Implications for placement of automated external defibrillators. Prehosp Emerg Care 2004; 8:10-14.
21. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 4: the automated external defibrillator: key link in the chain of survival. Circulation 2000; 102 (Suppl I):I60-76.
22. Frank RL, Rausch MA, Menegazzi JJ, Rickens M. The locations of nonresidential out-of-hospital cardiac arrests in the City of Pittsburgh over a three-year period: implications for automated external defibrillator placement. Prehosp Emerg Care 2001; 5:247-251.
23. Walker A, Sirel JM, Marsden AK, et al. Cost-effectiveness and cost-utility of public place defibrillators in improving survival following prehospital cardiopulmonary arrest. Br Med J 2003; 327:1316-1320.
24. Kuisma M, Castren M, Nurminen K. Public access defibrillation in Helsinki - costs and potential benefits from a community-based pilot study. Resuscitation 2003; 56:149-152.
25. Herlitz J, Bahr J, Fischer M, et al. Resuscitation in Europe: a tale of five European regions. Resuscitation 1999; 41:121-131.
26. Reed DB, Birnbaum A, Brown LH, et al., PAD Trial Investigators. Location of cardiac arrests in the public access defibrillation trial. Prehosp Emerg Care 2006; 10:61-76. Report from PAD triallists identifying locations with both highest incidence of cardiac arrest, and highest probability of survival.
27. Culley LL, Rea TD, Murray JA, et al. Public access defibrillation in out-of-hospital cardiac arrest. A community-based study. Circulation 2004; 109:1859-1863.
28. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002; 288:3008-3013.
29. Herlitz J, Andersson E, Bang A, et al. Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Goteborg. Eur Heart J 2000; 21:1251-1258.
30. Kuisma M, Repo J, Alaspa A. The incidence of out-of-hospital ventricular fibrillation in Helsinki, Finland, from 1994 to 1999. Lancet 2001; 358:473-474.
31. Parish DC, Dinesh Chandra KM, Dane FC. Success changes the problem: why ventricular fibrillation is declining, why pulseless electrical activity is emerging, and what to do about it. Resuscitation 2003; 58:31-35.
32. Lerner EB, Malo RF, Garrison HG, et al. Economic value of out-of-hospital emergency care: a structured literature review. Ann Emerg Med 2006; 47:515-524. Systematic review highlights paucity of high-quality cost-effectiveness or cost-utility data supporting prehospital interventions.
33. Nichol G, Wells GA, Kuntz K, et al. Methodological design for economic evaluation in Public Access Defibrillation (PAD) trial. Am Heart J 2005; 150:202-208.
34. Nichol G, Valenzuela T, Roe D, et al. Cost effectiveness of defibrillation by targeted responders in public settings. Circulation 2003; 108:697-703.
35. Woollard M. Public access defibrillation: a shocking idea? J Pub Health Med 2001; 18:98-102.
36. Nichol G, Hallstrom AP, Ornato JP, et al. Potential cost-effectiveness of public access defibrillation in the United States. Circulation 1998; 97:1315-1320.
37. Goldberg RJ, Gore JM, Love DG, et al. Laypersons CPR - are we training the right people? Ann Emerg Med 1984; 13:701-704.
38. Brennan RT, Braslow A. Are we training the right people yet? A survey of participants in public cardiopulmonary resuscitation classes. Resuscitation 1998; 37:21-25.
39. Nichol G, Laupacis A, Stiell IG, et al. Cost-effectiveness analysis of potential improvements to emergency medical services for victims of out-of-hospital cardiac arrest. Ann Emerg Med 1996; 27:711-720.
40. Lee K, Angus D, Abramson N. Cardiopulmonary resuscitation: what cost to cheat death? Crit Care Med 1996; 24:2046-2052.
41. Groeneveld PW, Kwong JL, Liu Y, et al. Cost-effectiveness of automated external defibrillators on airlines. JAMA 2001; 286:1482-1489.
42. Groeneveld PW, Owens DK. Cost-effectiveness of training unselected layperson in cardiopulmonary resuscitation and defibrillation. Am J Med 2005; 118:58-67. Training unselected laypersons in CPR/defibrillation carries a cost per QALY of >$200 000. Training laypersons selected by occupation, low training costs, or residence with high-risk individuals cost <$75 000 per QALY.
43. Cram P, Vijan S, Katz D, Fendrick AM. Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death. There's no place like home? J Gen Intern Med 2005; 20:251-258. Cost-effectiveness estimates of providing home AEDs according to risk of sudden death range from $216 000 to $88 000 per life-year gained.
44. Wang LY, Yang Q, Lowry R, Wechsler H. Economic analysis of a school-based obesity prevention program. Obes Res 2003; 11:1313-1324.
45. Olsen J, Willaing I, Ladelund S, et al. Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease. Int J Technol Assess Healthcare 2005; 21:194-202.
46. National Institute for Health and Clinical Excellence. Smoking Cessation - buproprion and nicotine replacement therapy. 2002. http://www.nice.org.uk/ page.aspx?o=TA39&c=publichealth.
47. Selmer RM, Kristiansen IS, Haglerod A, et al. Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health 2000; 54:697-702.
48. Pignone M, Earnshaw S, Tice JA, Pletcher MJ. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Intern Med 2006; 144:326-336.
49. Gaspoz JM, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002; 346:1800-1806.
50. Phillips KA, Shlipak MG, Coxson P, et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 2000; 284:2748-2754.
51. Mason JM, Freemantle N, Gibson JM, New JP. SPLINT trial Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trial. Diabetes Care 2005; 28:40-46.